Alexandra Power-Hays

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Sickle Cell Disease

Emergency Department

Randomized Controlled Trial

Top Venues

American journal of hematology

Pediatric blood & cancer

The New England journal of medicine

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology 99 (4) (2024)
Alexandra Power-Hays, George A Tomlinson, Mariane de Montalembert, Brígida Santos, Thomas N Williams, Peter Olupot-Olupot, Luke R Smart, Banu Aygun, Adam Lane, Susan E Stuber, Teresa Latham, Russell E Ware
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial. American journal of hematology (2024)
Alexandra Power-Hays, Min Dong, Nieko C Punt, Tomoyuki Mizuno, Luke R Smart, Alexander A Vinks, Russell E Ware
Rationale, development, and validation of HdxSim, a clinical decision support tool for model-informed precision dosing (MIPD) of hydroxyurea for children with sickle cell anemia. Clinical pharmacology and therapeutics (2023)
Alexandra Power-Hays, Christopher E Dandoy, Angela Lorts, John P Perentesis, Ndidi Unaka, Russell E Ware, Patrick T McGann
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity. Pediatric blood & cancer 69 (8) (2022)
Edwin Nieblas-Bedolla, Briana Christophers, John R Williams, Alexandra Power-Hays, Nathalia Jimenez, Analiz Rodriguez
Racial and ethnic disparities among children with primary central nervous system tumors in the US. Journal of neuro-oncology 152 (3) (2021)
Alexandra Power-Hays
It takes a village to raise a sickle cell warrior. Pediatric blood & cancer 68 (4) (2021)
Alexandra Power-Hays, Alyssa Patterson, Amy E Sobota
Household material hardships impact emergency department reliance in pediatric patients with sickle cell disease. Pediatric blood & cancer 67 (10) (2020)
Alexandra Power-Hays, Patrick T McGann
When Actions Speak Louder Than Words - Racism and Sickle Cell Disease. The New England journal of medicine 383 (20) (2020)
Alexandra Power-Hays, Stephanie Li, Akosua Mensah, Amy E Sobota
Universal screening for social determinants of health in pediatric sickle cell disease: A quality-improvement initiative. Pediatric blood & cancer 67 (1) (2019)